Articles On Medical Developments International (ASX:MVP)

Alloggio Group (ASX:ALO), didn’t have a positive debut on the ASX last week but that didn’t stop one director from buying more on market. The holiday accommodation manager listed at 20 cents per share but fell as low as 15 cents on debut am...

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays.   Theme of the week The Healthc...

The Medical Developments International Ltd (ASX: MVP) share price has fallen to a new 52-week low today. The company hasn’t released any news for nearly a fortnight. However, the last time the market heard from Medical Developments, it sha...

Highlights In the opening trade, the ASX 200 was trading 4.8 points up at 7,507.8, with the materials sector stocks opening in green on soaring commodities prices. Six out of the 11 sectors are trading in green, with the Materials sect...

The Medical Developments International (ASX: MVP) share price is lower after the company released its full-year results for FY21. At the time of writing, shares in the company are trading for $3.93 – down 2.48%. The ASX All Ordinaries Inde...

In afternoon trade, the S&P/ASX 200 Index (ASX: XJO) on course to end the week in a subdued fashion. At the time of writing, the benchmark index is down slightly to 7,335.6 points. Four ASX shares that are falling more than most are li...

The Medical Developments International Ltd (ASX: MVP) share price has come under pressure on Friday. At the time of writing, the medical device company’s shares are down 8% to a 52-week low of $4.03. This means the Medical Developments Int...

The deal gives IHL a global partner to develop the drug and navigate the global regulatory backdrop. Incannex Healthcare (ASX:IHL) flagged another key step forward this morning in the clinical development and manufacture of its IHL-216A tre...

With health issues at the global forefront over the past year, it’s no surprise that Australia’s health-related sector has also grown substantially. But the industry was already emerging even before COVID-19. Excellent research facilities a...

Every so often, I like to take a look to see which shares have experienced meaningful insider buying. This is because insider buying is often regarded as a bullish indicator, as few people know a company and its intrinsic value better than...

Source: REDPIXEL.PL, Shutterstock Summary Medical Developments International highlighted that despite a challenging H1, the Company anticipates a much stronger H2 FY2021. Future performance to be driven by easing restrictions, ongoing...

The Medical Developments International Ltd (ASX: MVP) share price has been a strong performer on Monday. In afternoon trade, the medical device company’s shares are up 7% to $5.37. Why is the Medical Developments International share price...

The Medical Developments International Ltd (ASX: MVP) share price was a strong performer on Thursday. The healthcare company’s shares closed the day a sizeable 5% higher at $7.18. This means the Medical Developments International share pri...

The Rhythm Biosciences Ltd (ASX:RHY) share price has rocketed over 640% for the past twelve-month period. From the beginning of November alone, the share price has soared over 355%.  For the past few weeks, we’ve been watching Rhythm Biosc...

In afternoon trade the S&P/ASX 200 Index (ASX: XJO) is on course to record a solid gain. At the time of writing, the benchmark index is up 0.5% to 6,677.4 points. Four shares that have failed to follow the market higher today are liste...

The Medical Developments International Ltd (ASX: MVP) share price has returned from its trading halt and is sinking lower on Monday morning. In early trade the healthcare company’s shares were down as much as 8.5% to $6.51. The Medical Dev...

In afternoon trade the S&P/ASX 200 Index (ASX: XJO) looks set to end the week on a strong note. At the time of writing, the benchmark index is up 0.5% to 6,646.2 points. Four shares that have failed to follow the market higher today ar...

The Medical Developments International Ltd (ASX: MVP) share price will be on watch on Friday following the release of an update after the market close. What did Medical Developments International announce? This afternoon Medical Developmen...

Lifespot Health (ASX: LSH) is further enhancing its leadership team and topping up cash reserves as it advances the development of its medical cannabis inhaler device program it claims will “significantly evolve the treatment options for pa...

The S&P/ASX 200 Index (ASX: XJO) has risen by 4.67% since last Friday’s close (6 November) to 6,466 points. Global investors have snapped up pandemic-hit shares after Pfizer Inc. (NYSE: PFE) indicated that its COVID-19 vaccine had prov...

The Medical Developments International Ltd (ASX: MVP) share price is on course to finish the week on a low note. In afternoon trade the healthcare company’s shares are down over 2% to $5.30. Why is the Medical Developments International sh...

The Medical Developments International Ltd (ASX: MVP) share price is pushing higher on the day of its annual general meeting. In afternoon trade the healthcare company’s shares are up 2.5% to $5.44. In case you missed the event, I thought...

Medical Developments International (ASX:MVP), the maker of the Penthrox (methoxyflurane) ‘green whistle’, has announced the appointment of Brent MacGregor as its new CEO.

The Medical Developments International Ltd (ASX: MVP) share price has surged 11.83% to $5.86 at the time of writing, after coming out of a trading halt this morning. Medical Developments had asked for a trading halt ahead of today’s announ...

The Medical Developments International Ltd (ASX: MVP) share price has fallen hard since COVID-19 put the world at a standstill. Between 19 February and 22 March, the Medical Developments share price took a sharp nosedive, falling from $11....

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays.   Themes of the week Two out of...

The Medical Developments International Ltd (ASX: MVP) share price was out of form on Thursday. The healthcare company’s shares tumbled 9% lower to $6.04 following the release of its preliminary full year results. How did Medical Developmen...

Medical Developments International (ASX:MVP) has a tentative contract with the Mundipharma network in Europe to take back the distribution rights for its pain relief drug, Penthrox, in all 27 member states in the European Union. The stock j...

The Medical Developments International Ltd (ASX: MVP) share price returned from its trading halt and zoomed higher today. The healthcare company’s shares were up as much as 14% to $7.15 at one stage. At the time of writing the Medical Deve...

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays.   Themes of the week With quart...

As the economic outlook grows increasingly gloomy, many investors may be thinking of diversifying into defensive companies as a way of strengthening their portfolios. Generally, healthcare companies provide a good defence against a downtur...

Long-term shareholders of emerging ASX healthcare company Opthea Ltd (ASX: OPT) have endured a volatile 12 months. A little under a year ago, the Opthea share price was trading at a 52-week low of just $0.735. Then, in the space of a month...

Like many companies, junior ASX healthcare company Medical Developments International Limited (ASX: MVP) has had a volatile 2020. After soaring to an all-time high of $11.78 in February, the Medical Developments share price was savaged in...

“Your Stock Request” is a weekly video where we analyse share price charts for stocks on the Australian market (ASX) as requested by you! Email us at [email protected] with your stock request. Limit of one per person, no guarantee o...

Want to know which stocks the fund managers have been putting their money in (and out) of? We’ve been keeping track so you don’t have to. Trading Places is Stockhead’s recap of substantial holder movements among ASX small caps in the last f...

Are you wanting to buy ASX shares today but are unsure where to look? Below are two ASX shares I would consider placing $5000 in for the next 3–5 years. Medical Developments International Ltd (ASX: MVP) Familiarity is a great place to st...

Medical Developments International (ASX:MVP) has announced the approval of pain reliever PENTHROX (methoxyflurane) in Thailand.

Well, are you? Here’s why I think it’s important to be prepared for the ASX to fall again. Where are we now? The All Ordinaries (ASX: XAO) fell almost 40% in late February to late March, with the S&P/ASX 200 Index (ASX: XJO) riding its...

Buying shares on the ASX doesn’t necessarily mean the business operates solely within Australian borders – after all, the world is a big place and Australia is only a relatively small market. So to accelerate growth, many companies look ac...

Investing in the ASX has no doubt felt a bit like a roller coaster over the past couple of months. The ALL ORDINARIES (ASX: XAO) fell almost 40% in March from its February highs, with the S&P/ASX 200 Index (ASX: XJO) not far behind, fa...

Is it time to buy Vanguard Australian Share ETF (ASX: VAS)? Vanguard Australian Share ETF is an exchange traded fund (ETF) focused on tracking the ASX 300 (ASX: XKO). What is Vanguard? I think Vanguard is great. Vanguard is a world leader...

Amid the insane volatility of financial markets, the CSL Limited (ASX: CSL) share price is actually trading more than 15% higher for the year. The company’s strong performance reflects its status as one of the finest shares listed on the A...

The Medical Developments International Ltd (ASX: MVP) share price is up 3.65% today, but Medical Developments shares have not been spared by the current market volatility, plunging more than 50% since mid-February.   Here’s why analysts ra...

We asked our Foolish writers to pick their favourite ASX stocks to buy in April.  Despite the coronavirus pandemic causing widespread volatility across global markets, we still see opportunities to buy amongst ASX shares.  So here is what...

The Medical Developments International Ltd (ASX: MVP) share price is pushing higher on Tuesday after releasing an update on the impact of the coronavirus on its business. At the time of writing the healthcare company’s shares are up 3.5% t...

The ASX healthcare sector continues to be one of the top performers on the ASX in terms of share price rises over the past 12 months, despite all the strong market correction. While most Australians are likely familiar with healthcare comp...

With coronavirus absolutely smashing global markets, investors and the public are turning to biotech companies for a solution. Currently, there is a global rush of medical trials to find a vaccine or medical product that could halt the cor...

Neuren Pharmaceuticals (ASX: NEU) is getting interesting results from a mouse trial of a treatment for Phelan-McDermid syndrome (PMS), a rare genetic illness which exhibits symptoms of conditions including autism and epilepsy. The study fou...

Neuroscience tech company Cogstate (ASX:CGS) produced some much needed good news today, saying it has executed $9.1m of clinical trials sales contracts since the start of 2020. The stock — up about 30 per cent on the news — says this revenu...

Medicall Developments International (ASX: MVP), the company responsible for a range of products including pain drug inhaler Penthrox, has announced the resignation of its CEO